Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRAF V600 Detection and Vemurafenib + Cobimetinib in Advanced Melanoma
NCT02768207Phase 2Completed
- Sponsor
- Roche
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vemurafenib, cobimetinib in melanoma, sponsored by Roche. Started May 2016; status: completed.
02
Drugs
vemurafenibcobimetinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02768207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768207.